Assessing alpha-tocopherol levels in patients with keratocystic odontogenic tumor: A cross-sectional study | Zendy

Bhargavi Krishna | Zendy; SushmitaBhargavi Varikoti | Zendy; PachaVenkat Baghirath | Zendy; BHari Vinay | Zendy; Ch Gayathri | Zendy; Ashalata Gannepalli | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Assessing alpha-tocopherol levels in patients with keratocystic odontogenic tumor: A cross-sectional study

Author(s) -

Bhargavi Krishna,

SushmitaBhargavi Varikoti,

PachaVenkat Baghirath,

BHari Vinay,

Ch Gayathri,

Ashalata Gannepalli

Publication year - 2017

Publication title -

indian journal of dental research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 43

eISSN - 1998-3603

pISSN - 0970-9290

DOI - 10.4103/ijdr.ijdr_714_16

Subject(s) - keratocystic odontogenic tumor , vitamin d and neurology , medicine , vitamin e , vitamin , biology , endocrinology , gastroenterology , pathology , physiology , antioxidant , odontogenic , biochemistry

A keratocystic odontogenic tumour (KCOT) is a benign uni- or multicystic, intraosseous tumour of odontogenic origin, with a characteristic lining of parakeratinized stratified squamous epithelium and potential for aggressive, infiltrative behaviour. Various studies in hamsters showed that, alpha-Tocopherol, which is an active biological form of Vitamin E, is a potent antioxidant known to inhibit tumour formation and also regression of established tumours. So, the aim of the present pilot study was to assess the levels of Alpha-Tocopherol(Vitamin E) in Patients with KCOT and compare them with Vitamin E levels in normal healthy individuals.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research